GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Debt-to-Equity

Alpa Laboratories (NSE:ALPA) Debt-to-Equity : N/A (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Debt-to-Equity?

Alpa Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Alpa Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Alpa Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Alpa Laboratories's Debt-to-Equity or its related term are showing as below:

NSE:ALPA' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.05   Max: 0.33
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Alpa Laboratories was 0.33. The lowest was 0.00. And the median was 0.05.

NSE:ALPA's Debt-to-Equity is ranked better than
99.88% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs NSE:ALPA: 0.01

Alpa Laboratories Debt-to-Equity Historical Data

The historical data trend for Alpa Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Debt-to-Equity Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 - - 0.05 0.02

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.02 N/A 0.01 N/A

Competitive Comparison of Alpa Laboratories's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpa Laboratories's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Debt-to-Equity falls into.


Alpa Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alpa Laboratories's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(15.269 + 7.771) / 1345.775
=0.02

Alpa Laboratories's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories  (NSE:ALPA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Alpa Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpa Laboratories (NSE:ALPA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Debt-to-Equity
Comparable Companies
BOM:524518 BOM:531173 BOM:537536 BOM:532637 NSE:VAISHALI BOM:524824 BOM:532384 BOM:530313 NSE:SOTAC BOM:540702 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532878:India
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Website
https://www.alpalabs.in
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.